EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA G‐Quadruplex RIBOTAC‐Mediated Targeted Degradation of lncRNA TERRA

Elias Khaskia, Dipak Dahatonde, Raphael I Benhamou iD

Advanced Science · 2025-12 · 12 (48)

DOI: 10.1002/advs.202512715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.10.2025. Verfasst von Elias Khaskia und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112002, Israel. Hauptthemen laut MEDLINE: RNA, Long Noncoding, G-Quadruplexes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Cancer Research Fund, Israel Science Foundation, Neubauer Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long noncoding RNAs (lncRNAs) regulate gene expression and play crucial roles in development and disease, including cancer. One important but still poorly understood lncRNA is TERRA (telomeric repeat‐containing RNA), transcribed from telomeres and essential for telomere maintenance, genome stability, and cellular aging. TERRA adopts two structural features,R‐loops and G‐quadruplexes (G4s), that drive its biological activity. Its dysregulation is linked to telomere dysfunction and is prominent in Alternative Lengthening of Telomeres (ALT) cancers, where TERRA is highly upregulated and promotes telomere recombination. Here, first‐in‐class small molecules targeting TERRA using RIBOTAC (Ribonuclease‐Targeting Chimera) technology is developed. These compounds selectively bind TERRA's G4 structures and recruit RNase L, inducing its degradation while sparing DNA G4s and other G4 RNAs. This selectivity results from ternary complex formation with RNase L and the repetitive G4 motifs enriched in TERRA. TERRA‐RIBOTACs in HeLa and U2OS cells, the latter representing an ALT cancer model, are evaluated. TERRA degradation, particularly at 7p, 13q, 15q, and 20q loci, impairs telomere function and reduces colony formation. Manipulating lncRNAs like TERRA with chemical tools opens new avenues for drug development and deepens the understanding of RNA‐based regulation in cancer biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingG-QuadruplexesHumansTelomereHeLa CellsCell Line, TumorTelomere Homeostasis

Stichwörter der Autor:innen

G‐quadruplexRIBOTACalternative lengthening of telomereslncRNAsmall moleculestargeted degradation

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112002, Israel.

ORCID-Profile: Raphael I Benhamou

Förderung

  • Israel Cancer Research Fund
  • Israel Science Foundation
  • Neubauer Family Foundation
  • Israeli Centers for Research Excellence

Zitieren

APA

Khaskia, E., Dahatonde, D., & Benhamou, R. I. (2025). RNA G‐Quadruplex RIBOTAC‐Mediated Targeted Degradation of lncRNA TERRA. Advanced Science, 12(48). https://doi.org/10.1002/advs.202512715

Vancouver

Khaskia E, Dahatonde D, Benhamou RI. RNA G‐Quadruplex RIBOTAC‐Mediated Targeted Degradation of lncRNA TERRA. Advanced Science. 2025;12(48). doi:10.1002/advs.202512715

BibTeX
@article{Khaskia2025,
  author = {Khaskia, Elias and Dahatonde, Dipak and Benhamou, Raphael I},
  title = {RNA G‐Quadruplex RIBOTAC‐Mediated Targeted Degradation of lncRNA TERRA},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {48},
  doi = {10.1002/advs.202512715}
}
Kostenlos starten →